# Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV)

> **NCT00947141** · PHASE4 · COMPLETED · sponsor: **University College, London** · enrollment: 165 (actual)

## Conditions studied

- Viraemia

## Interventions

- **DRUG:** ganciclovir (start when CMV PCR >200copies / ml x2)
- **OTHER:** Monitor (Treatment starts when CMV PCR >3,000 copies / ml)
- **DRUG:** Stop treatment when 2 levels CMV PCR <3,000 copies / ml
- **OTHER:** Monitor (Treatment stops CMV PCR <200 copies / ml x2)

## Key facts

- **NCT ID:** NCT00947141
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** 2011-12
- **Final completion:** 2013-02
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2017-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00947141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00947141, "Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00947141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*